Cargando…
Preparation and Solid-State Characterization of Eltrombopag Crystal Phases
Eltrombopag, of C(25)H(22)N(4)O(4) chemical formula, is a drug used against thrombocytopenia, marketed worldwide under different tradenames in the form of its bis-olamine salt. The free acid (CAS no. 496775-61-2) is an intermediate species used for the final drug isolation and is reported to crystal...
Autores principales: | Abbinante, Vincenzo Mirco, Zampieri, Massimo, Barreca, Giuseppe, Masciocchi, Norberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795200/ https://www.ncbi.nlm.nih.gov/pubmed/33375645 http://dx.doi.org/10.3390/molecules26010065 |
Ejemplares similares
-
Thermal and Structural Characterization of Two Crystalline Polymorphs of Tafamidis Free Acid
por: Masciocchi, Norberto, et al.
Publicado: (2022) -
Eltrombopag with gemcitabine-based chemotherapy in patients with advanced solid tumors: a randomized phase I study
por: Winer, Eric S, et al.
Publicado: (2015) -
Eltrombopag in Good's Syndrome
por: Kristiansen, Håvard Anton, et al.
Publicado: (2014) -
Adding cyclosporin A to eltrombopag for aplastic anemia secondary to chemotherapy for solid cancers
por: Wan, Ziqi, et al.
Publicado: (2023) -
Eltrombopag for the treatment of inherited thrombocytopenias: a phase II clinical trial
por: Zaninetti, Carlo, et al.
Publicado: (2020)